Prof. Dr. R.T. Grundmann
Aus World J Gastrointest Surg 2011; 3: 183-196
It is the objective of this article to give an overview on surgical treatment of patients with colorectal liver metastases (CLM) on the basis of a workflow that has been elaborated recently by an expert group . The present update will focus on hepatic resection only as the procedure of choice for curative treatment of CLM. Hepatectomy allows 10-year survival rates of 16%  to 23 % . The efficacy of ablative procedures such as radiofrequency ablation (RFA) will not be considered since the results of a panel of the American Society of Clinical Oncology (ASCO) demonstrate a compelling need for more research to determine the efficacy and utility of RFA to increase local recurrence-free, disease-free, and overall survival for patients with CLM .
Lesen Sie den ganzen Artikel (PDF-Download):
Current state of surgical treatment of liver metastases from colorectal cancer